Tag: Drug Registration

MSD Plans to Register Four New Medicinal Products in the Russia in the Аirst Рalf of 2020

“The highlight is really the acceleration of access to our innovation. We always have provided and registered our products here, but this year was truly a leap year. We registered for example four pro...

Allergan’s Ubrogepant under Registration for Treatment of Acute Migraines

Irish pharmaceutical company Allergan’s ubrogepant is currently in pre-registration for the treatment of acute migraines. It’s an oral pill belonging to a novel class of medications known as calcitoni...

Russian Ministry of Health Registered First Drug in Accordance with EAEU Requirements

The Ministry of Health of the Russian Federation issued the first registration certificate prepared in accordance with Decision of the Council of the Eurasian Economic Commission dated November 3, 201...

Russia Will Register Drug only in Accordance with EAEU Rules since 2021

The Ministry of Industry and Trade of the Russian Federation proposes from January 1, 2021 to register new drugs for medical use only within the framework of the rules of the Eurasian Economic Union, ...

17 Drugs Registered in the Russian Federation, including Generic Pomalidomide

The Russian Ministry of Health approved the first generic immunomodulator pomalidomide for the treatment of orphan disease - multiple myeloma. Information on this is available on the website of the St...

Procedure for Registering Drugs in Russia is Too Long, Accounts Chamber Discovered

The Accounts Chamber of the Russian Federation in its analysis of state programs as part of the Opinion on the draft federal law “On the federal budget for 2020 and the planning period 2021 and 2022” ...

EEC Board Adopted Directory of Structural Elements of Drug Registration Dossier

On September 19, 2019, the Decision of the EEC Board No. 159 “On the classifier of types of documents for the registration dossier of a medicinal product and the reference book of structural elements ...

Results of FAS Head and Association of European Businesses’ Members Meeting

The Working Groups will help solve particular competition issues. A traditional meeting of Head of FAS, Igor Artemiev, with representatives of the Association of European Businesses focused on the ...

The Ministry of Health of the Russian Federation improves patent protection law

The Ministry of Health of Russia has published a notification on the development of amendments to Federal Law No. 61 of 12.04.2010 "On circulation of medicinal products"

Six new antiepileptic drugs will be registered in Russia

Six more drugs are in the final stage of clinical trials, Veronika Skvortsova, Minister of Health of the Russian Federation said at a briefing.

Sechenov University completed the creation of new Pharmacy training programs

Department of Pharmaceutical and Toxicological Chemistry of the Institute of Pharmacy at the Sechenov University and their foreign partners have completed creation of the new training programs.

Inflation rate should be considered during drug registration procedure in Russia

The Federal Antimonopoly Service draws the attention of owners or holders of registration certificates of medicines included in the list of vital and essential drugs (VED).

The Ministry of Health of Uzbekistan will reform drug provision

In 2018, 914.6 billion sums will be allocated to ensure the procurement of medicinal products and medical devices for state medical institutions in Uzbekistan, which is 2.5 times more than in 2017.

Mepolizumab for eosinophilic asthma treatment was registered in Russia

GSK announced the registration of Nucala (mepolizumab) in the Russian Federation to be used as add-on maintenance treatment for severe eosinophilic asthma in patients over 18 years old.

Russia has the shortest period of drug registration to date

This was announced by the Minister of Health the Russian Federation, Veronika Skvortsova, at an expanded meeting of the State Duma Committee on Health Protection.

AstraZeneca resumes sales of Nexium in Russia

AstraZeneca, a biopharmaceutical company, announced that it registered new maximum ex-work prices in Russia for the tablets of Nexium (esomeprazole) included in the List of Vital and Essential Drugs (VED List).